Sarcoma Clinical Trials Available Near Brandon, FL
For individuals who are considering sarcoma clinical trials, Moffitt Cancer Center offers a wide range of opportunities near Brandon, Florida. Our research efforts are recognized by the National Cancer Institute (we are the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida), and thousands of patients have enrolled in our trials to access newer and more effective therapies before those options became available in other settings.
Each clinical trial conducted at Moffitt has a different focus, as well as a different set of participation criteria. For instance, some studies are open to all individuals with a certain condition, while other studies focus on people with specific diagnoses (e.g., adults with late-stage sarcoma or children with osteosarcoma). Our experienced oncologists can help a patient evaluate our current schedule of studies and decide if one of our sarcoma clinical trials is right for his or her needs.
Through our clinical trials program, we make it possible for residents of Brandon and other nearby areas to access the latest advances in sarcoma treatment close to home. These options include:
- Immunotherapies
- Novel chemotherapy medications
- Targeted treatments
- Newer and more effective supportive care services to counteract the side effects of treatment
No matter what treatments our patients choose, we’re here to help them achieve the best possible outcome and quality of life. For more information about our sarcoma clinical trials, call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online. Moffitt Cancer Center welcomes patients from Brandon, FL, and all other nearby areas. We do not require referrals.
Sarcoma
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous Lymphoma (CTCL)
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer